BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Catalyst Brief//FDA catalyst calendar//KO
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Catalyst Brief — FDA 일정 캘린더
REFRESH-INTERVAL;VALUE=DURATION:PT6H
X-PUBLISHED-TTL:PT6H
BEGIN:VEVENT
UID:event-3@catalystbrief.girapphe.com
DTSTAMP:20261117T024426Z
LAST-MODIFIED:20261117T024426Z
DTSTART;VALUE=DATE:20270325
DTEND;VALUE=DATE:20270326
SUMMARY:승인 결정일(PDUFA): Unicycive Therapeutics\, Inc. (UNCY) — o
 xylanthanum carbonate (OLC)
DESCRIPTION:투석 만성콩팥병 고인산혈증 치료제 OLC 신약 재
 신청(NDA) FDA PDUFA 목표 심사일.\n출처: https://www.sec.gov/Archi
 ves/edgar/data/1766140/000121390026120261/ea031236501ex99-1.htm\nhttps://c
 atalystbrief.girapphe.com/e/3?lang=ko\n투자 조언이 아닙니다. 일
 정은 변경될 수 있습니다.
URL:https://catalystbrief.girapphe.com/e/3?lang=ko
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
